Die Klinikum Chemnitz gGmbH ist ein Krankenhaus der Maximalversorgung in Chemnitz. Es ist das größte kommunale Krankenhaus in Ostdeutschland und Akademisches Lehrkrankenhaus der Universitäten von Leipzig, Dresden und Prag.

During the past decade, Klinikum Chemnitz gGmbH conducted 85 clinical trials. In the 10-year time frame, 85 clinical trials started and 24 clinical trials were completed, i.e. on average, 28.2% percent of trials that started reached the finish line to date. In the past 5 years, 40 clinical trials started and 20 clinical trials were completed. i.e. 50% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Klinikum Chemnitz gGmbH" #1 sponsor was "Hoffmann-La Roche" with 9 trials, followed by "Technische Universität Dresden" with 8 trials sponsored, "Pfizer" with 6 trials sponsored, "German High-Grade Non-Hodgkin's Lymphoma Study Group" with 5 trials sponsored and "Boehringer Ingelheim" with 5 trials sponsored. Other sponsors include 90 different institutions and companies that sponsored additional 75 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Klinikum Chemnitz gGmbH" #1 collaborator was "German Research Foundation" with 3 trials as a collaborator, "Ludwig-Maximilians - University of Munich" with 3 trials as a collaborator, "Deutsche Kinderkrebsstiftung" with 2 trials as a collaborator, "Hoffmann-La Roche" with 2 trials as a collaborator and "Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest" with 2 trials as a collaborator. Other collaborators include 81 different institutions and companies that were collaborators in the rest 89 trials.

According to Clinical.Site data, the most researched conditions in "Klinikum Chemnitz gGmbH" are "Multiple Myeloma" (10 trials), "Acute Myeloid Leukemia" (7 trials), "Ovarian Cancer" (7 trials), "Lymphoma" (6 trials) and "Leukemia" (5 trials). Many other conditions were trialed in "Klinikum Chemnitz gGmbH" in a lesser frequency.

Most popular intervention types in "Klinikum Chemnitz gGmbH" are "Drug" (99 trials), "Biological" (19 trials), "Procedure" (14 trials), "Device" (13 trials) and "Radiation" (11 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (12 trials), "Carboplatin" (11 trials), "cyclophosphamide" (10 trials), "doxorubicin hydrochloride" (9 trials) and "radiation therapy" (9 trials). Other intervention names were less common.

The vast majority of trials in "Klinikum Chemnitz gGmbH" are 114 trials for "All" genders and 13 trials for "Female" genders.

Currently, there are NaN active trials in "Klinikum Chemnitz gGmbH". undefined are not yet recruiting, 36 are recruiting, 23 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 42 completed trials in Klinikum Chemnitz gGmbH, undefined suspended trials, and 20 terminated clinical trials to date.

Out of the total trials that were conducted in Klinikum Chemnitz gGmbH, 4 "Phase 1" clinical trials were conducted, 39 "Phase 2" clinical trials and 62 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 7 trials that are defined as “Not Applicable".

Klinikum Chemnitz gGmbH has several departments that took part in Clinical trials: "Klinikum Chemnitz gGmbH / Klinik für Innere Medizin III" - 15 trials, "Klinikum Chemnitz gGmbH, Klinik für Kinder- und Jugendmedizin, Päd. Hämatologie und Onkologie" - 4 trials, "Department of Neurology, Klinikum Chemnitz gGmbH" - 3 trials